Unknown OBSERVATIONAL NCT03291262

Survival Outcomes of Ovarian Malignancies in Chinese Population

Sponsor: Lei Li

Interventions Follow up for death and recurrence

Updated 10 times since 2017 Last updated: Nov 9, 2018 Started: Jan 1, 2017 Primary completion: Jan 1, 2022 Completion: Jan 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Ovarian Neoplasms and Survival, this trial is ongoing. The trial is conducted by Lei Li and has accumulated 10 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Feb 2023 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jan 2021 — Feb 2023 [monthly]

Recruiting
Dec 2018 — Jan 2021 [monthly]

Recruiting

▶ Show 5 earlier versions

Aug 2018 — Dec 2018 [monthly]

Recruiting
Jul 2018 — Aug 2018 [monthly]

Recruiting
Jun 2018 — Jul 2018 [monthly]

Recruiting
Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Oct 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

Jan 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lei Li

Data source: Peking Union Medical College Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China